1. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
2. The Central Research Fund fee collected by the Authority will be utilized for:
3. What is the primary function of the Federal Drug Laboratory as stated in the rules?
4. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
5. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
6. The Authority shall levy and collect fees for its functions at rates determined by:
7. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
8. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
9. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
10. What are "Medical Devices" under Schedule-I?
11. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
12. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
13. Which type of research involves intervention, treatment, or medication programs using human subjects?
14. Who serves as the ex-officio Chairman of the Appellate Board?
15. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
16. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
17. What is the fee for the renewal of registration of a new drug?
18. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
19. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
20. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
21. What does an Inspector require from a person during a search or seizure under Schedule-V?
22. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
23. What is the commencement date for the Drugs (Specifications) Rules, 1978?
24. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
25. What does an Inspector require from a person during a search or seizure under Schedule-V?
26. What is the penalty for a person who fails to provide information requested by the Authority?
27. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
28. What action should the Authority take in response to objections raised by the Auditor-General?
29. Which power of the Inspector requires specific authorization by the Government?
30. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
31. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
32. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
33. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
34. Which of the following is NOT considered as "Therapeutic goods" under the Act?
35. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
36. Under what conditions are drug advertisements to the general public generally permitted?
37. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
38. What substances are NOT included in the definition of "Drug" under Schedule-I?
39. What is the purpose of the Drugs (Research) Rules, 1978?
40. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
41. In what circumstances shall a drug not be deemed misbranded or adulterated?
42. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
43. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
44. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
45. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
46. What must be included in the labelling and promotion of a registered drug?
47. What is the primary purpose of the Committee of Experts on Drug Research?
48. What is the Appellate Board's authority to call for the record of a case for review?
49. For drugs other than those falling under specific categories, whose approval is required for the specifications?
50. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
51. What are "Medicated Cosmetics" under Schedule-I?
52. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
53. In which situations may the Registration Board provisionally register a drug for a period of two years?
54. Who is responsible for maintaining records of quarterly production and disposal of a drug?
55. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
56. When does an Inspector need to divide a sample into three portoons instead of four?
57. What is the purpose of the license to manufacture drugs for experimental purposes?
58. Which of the following offenses punishable under Schedule-III is non-cognizable?
59. What is the tenure of the CEO's appointment, and how many times can it be extended?
60. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
61. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
62. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
63. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
64. What is the purpose of Schedule-III of the DRAP Act?
65. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
66. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
67. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
68. When can deviations be made from the information submitted during the registration of a drug?
69. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
70. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
71. How many members does the Policy Board consist of?
72. What is the short title of the rules that govern the Drugs Appellate Board?
73. What is the purpose of the criteria regarding medical representatives?
74. Who is considered an "investigator" under the Drugs (Research) Rules?
75. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
76. What does the term "Advertise" mean under Schedule-II?
77. What is the purpose of the Committee on Drugs Evaluation?
78. What is the duration of a license to import drugs, unless suspended or canceled?
79. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
80. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
81. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
82. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
83. What are "Medicated Cosmetics" under Schedule-I?
84. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
85. What is the purpose of an "airlock" in pharmaceutical manufacturing?
86. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
87. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
88. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
89. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
90. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
91. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
92. Who qualifies as a Federal Inspector according to these rules?
93. What are "Medical Devices" under Schedule-I?
94. What is the duration of a license to export drugs?
95. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
96. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
97. What is the purpose of an "airlock" in pharmaceutical manufacturing?
98. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
99. Which of the following statements about advertisement material is NOT true?
100. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
